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Abstract
Introduction: A relaparotomy for a pancreatic fistula (PF) after a pancreaticoduodenectomy (PD) is a
formidable operation, and the appropriate treatment of anastomotic leakage is under debate. The
objective of this study was to compare the outcomes of different strategies in managing the pancreatic
remnant during a relaparotomy for PF after a PD.
Methods: In this retrospective study on prospectively collected data, 669 PD were performed between
2004 and 2011. The study group comprised 31 patients requiring a relaparotomy, because of delayed
haemorrhage (n = 19) or sepsis (n = 12). The pancreatic stump was treated either using pancreas-
preserving techniques (simple drainage or duct occlusion) or completion of a pancreatectomy (CP). In
2008, autologous islet transplantation (AIT) was introduced for endocrine tissue rescue of CP.
Results: The mortality rate, blood loss and transfusion requirement were similar for all techniques.
Patients undergoing a CP required a further relaparotomy less frequently than patients with pancreas
preservation (7% versus 59%, P < 0.01), and the intensive care unit (ICU) stay was reduced after CP (P
= 0.058). PF persisted at discharge in 66% of patients after pancreas-preserving techniques. AIT was
associated with CP in 7 patients, of whom one died post-operatively. Long-term graft function was
maintained in four out of six surviving patients, with one insulin-independent patient at 36 months after
transplantation.
Conclusions: When a PF requires a relaparotomy, CP has become our favoured technique. AIT can
reduce the metabolic impact of the procedure.
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Introduction
A pancreaticoduodenectomy (PD) remains one of the more chal-
lenging abdominal operations. Although mortality rates have
reduced during the past 30 years owing to centralization to high-
volume centres,1 the overall morbidity still reaches 60%.2 The
most serious complications, such as late post-operative haemor-
rhage and sepsis, derive mainly from a post-operative pancreatic
fistula (PF) from a leaking pancreatic anastomosis. In spite of
previous studies claiming outstanding results in reducing leakage
rates, with almost no need for reoperation,3 the actual rate of a
severe (grade C) PF requiring a relaparotomy varies between 5%
and 20%2 even in experienced centres, with a mortality rate as
high as 39%.4 During a relaparotomy, different intra-operative
strategies have been described, including both preservation of the
pancreatic remnant and a completion pancreatectomy (CP).5
Pancreas-preserving approaches are technically easier than CP
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and have the advantage of maintaining pancreatic function but
they expose patients to the risk of further complications as a result
of a persistent PF. CP is a technically demanding operation that
inevitably leads to complete pancreatic insufficiency, character-
ized by a complex diabetic condition named ‘brittle’ diabetes.6
The objective of this retrospective analysis was to compare the
outcomes of different strategies in managing the pancreatic stump
during a relaparotomy for PF after a PD.
Patients and methods
Data were collected prospectively in an electronic pancreatic
surgery database and analysed retrospectively.
All procedures were carried out by experienced surgeons who
had completed a training programme in pancreatic surgery.7
The pancreatic anastomosis was performed in all patients as a
two-layer end-to-side pancreatico-jejunostomy on the proximal
jejunal limb. In the presence of risk factors for pancreatic anasto-
mosis leakage (soft pancreas, small pancreatic duct or both), the
pancreatic anastomosis was fashioned on a separate Roux-en-Y
jejunal limb. Prophylaxis with octreotide (0.1 mg three times a
day) was started in all patients on the day of surgery, continued
until post-operative day 7 in case of a high-risk anastomosis and
prolonged until discharge in case of PF.
One 28-French gauge tubular drain was placed routinely on the
posterior side of the pancreatico-jejunostomy. An extra drain was
placed on the anterior side in the event of a high-risk anastomosis.
Since 2010, flat Penrose drains were used instead of tubular drains.
All patients were treated according to an enhanced recovery
after surgery protocol.8 Post-operative complications were defined
according to our previous study.9The severity of post-operative
complications was graded according to Clavien–Dindo classifica-
tion,10 which was validated in pancreatic surgery.11 Complications
graded as III to V were considered as major. A PF was defined
according to the International Study Group for Pancreatic Surgery
criteria.12
In the event of a delayed post-operative haemorrhage, if the
patient was haemodynamically stable the treatment algorithm
included a diagnostic contrast-enhanced CT scan, followed by
interventional radiology with embolization or stenting for active
arterial bleeding. A relaparotomy was performed when there was
haemodynamic instability, failure to identify a source of bleeding
or failure of angiographic treatment. A relaparotomy was per-
formed when sepsis was associated with a peripancreatic fluid
collection not amenable to percutaneous drainage, or after failure
of percutaneous drainage.
Techniques of pancreatic stump treatment during
a relaparotomy
Pancreatic stump management during a relaparotomy included
three different techniques. Of the two preserving the pancreatic
stump, the first consisted of debridement and drainage of the
peripancreatic region (defined as simple drainage), the other
through the occlusion of the main pancreatic duct by prolamine
injection (Ethibloc®; Ethicon, Norderstedt, Germany), after
resecting the dehiscent jejunal loop previously anastomosed to the
pancreas. Prolamine was no longer available in our Institution
from September 2008. The third technique consisted of a CP, with
removal of the distal pancreas and splenectomy.
In most cases, the choice of the technique relied on the sur-
geon’s preference, but in other cases it was forced by the patient’s
conditions or intra-operative findings: patient’s severe haemody-
namic instability forced a pancreas-preserving technique, because
critical conditions ruled out the possibility of major surgery such
as a CP; intra-operative findings of necrotic pancreatitis associ-
ated with leakage made CP mandatory; and tough visceral adhe-
sions preventing access to the pancreatic stump, especially in case
of delayed re-operation, excluded the possibility of CP.
To reduce the potential bias because of non-homogeneous
patients undergoing a relaparotomy, the instances when there was
no possibility to choose between a pancreas-preserving technique
and CP were excluded from the study group.
In November 2008, autologous islet transplantation (AIT) was
introduced for endocrine-tissue rescue in case of CP. Exclusion
criteria for AIT were: pre-operative diabetes and the presence of
neoplasia in the pancreatic stump including a benign neoplasm
such as a multifocal intraductal papillary mucinous neoplasm. In
contrast, the diagnosis of malignancy in the previously removed
pancreatic head was not considered a contraindication for AIT if
frozen-section examination of the resection margin was normal.
The isolation process was performed as previously described.13,14
Islets were usually infused in the portal vein, by interventional
radiology through a percutaneous transhepatic approach the day
after surgery or by the surgeon during the relaparotomy (one
case). When patient instability did not allow an angiographic
procedure, intra-bone marrow transplantation was performed
(two cases).
Outcome measures assessed included mortality, the need for a
further relaparotomy or interventional radiology, intensive care
unit (ICU) duration of stay, blood loss and transfusion require-
ment, length of stay, persistence of PF at discharge and onset of
diabetes.
Statistical analysis
Data are shown separately for each of the three different tech-
niques. The outcomes of SD and DO (pancreas-preserving tech-
niques) were grouped for comparison versus CP. Descriptive data
are reported as mean (standard deviation), median (range) or
number of patients and percentage. Categorical variables were
compared using the chi-square test, continuous variables by the
Student’s t-test and non-parametric Mann-Whitney U-test.
Results
Between 1 January 2004 and 31 December 2011, 669 PD were
performed. Characteristics of the patients are listed in Table 1. In
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336 patients (50.2%) the anastomosis was fashioned on a separate
Roux-en-Y jejunal limb, owing to the presence of risk factors for
leakage. Table 2 shows the post-operative outcome of the entire
cohort in detail. A clinically relevant PF (grade B–C) occurred in
98 patients (14.6%); 37 (5.5%) underwent a relaparotomy (grade
C) and comprised the study group. Indications for relaparotomy
were: delayed haemorrhage (22 patients, 59.5%) and sepsis (15
patients, 40.5%).
Between 2004 and 2011, 37 patients underwent a relaparotomy
for pancreatic leakage after PD. Six of these patients were excluded
from the study as a result of intra-operative impossibility of
choosing between a pancreas-preserving technique and a CP: two
of these patients had necrotic pancreatitis of the stump and man-
datorily underwent CP, two were in a critical condition, unfit for
major surgery and in two further patients, the pancreatic stump
was inaccessible. Thus, the study population included 31 patients.
During a relaparotomy 17 patients (55%) underwent a
pancreatic-preserving procedure: 10 patients (32%) were treated
with simple drainage (SD) of the anastomotic region and 7
patients (23%) with pancreatic duct occlusion (DO) with
prolamine. The remaining 14 (45%) patients underwent a CP.
Since 2008, nine of these patients were candidates for AIT and
seven (78%) successfully received AIT. The other two patients
were excluded owing to severe bacterial contamination of the islet
solution in one instance and because of haemodynamic instability
in the other.
The median post-operative day of relaparotomy was day 13,
and was similar in the three groups, with no difference in the cause
of relaparotomy between the groups. Table 3 shows patient char-
acteristics at the time of relaparotomy.
Operative time and intra-operative blood loss were significantly
higher in patients treated with CP. However, a significantly higher
number of patients treated using pancreas-preserving techniques
required extra reoperations (10 patients, 59% versus 1 patient,
7%). These further reoperations were mainly because of relapsing
haemorrhagic complications, which were more frequent in
patients with pancreatic stump preservation. Considering the
whole post-operative course, including all further relaparotomies,
overall blood loss was not different between the groups with an
overall similar transfusion volume.
Overall mortality was 25.8%, and did not differ between the
groups. The causes of mortality were multiple organ failure in five
patients, respiratory failure in two patients and hemorrhagic shock
in one patient. In patients treated by CP, only one of 11 patients
(9.1%) has died since 2008. Post-operative morbidity was similar
between the groups (Table 4). More patients were admitted to the
ICU after a CP, but the mean ICU stay per patient was higher in
patients in whom the pancreas was preserved. This seemed to be
related to the persistence of sepsis or haemorrhagic relapse.
Hospital length of stay (LOS) after a relaparotomy was slightly
lower in patients undergoing CP compared with pancreas-
preserving procedures. The mean LOS was 22.4 compared with
34.4 days (P-value = 0.103). This difference may reflect the higher
number of post-operative sequelae in the group of patients who
received a pancreas-sparing procedure. In this group, 8 out of 12
of the surviving patients (66%) had a persistent PF at the time of
discharge.
Patients who underwent AIT received a mean number of 1806
 513 equivalent islets per kilogram of body weight. AIT-
associated complications occurred in two patients (29%): one
patient had a septic exacerbation minutes after islet infusion; in
another patient with sepsis, transient portal thrombosis was
observed.
Table 1 Baseline and intra-operative data of the entire cohort
All patients
(n = 669)
Age (years) 64.6 (11.2)
Gender:
Male 397 (59%)
Female 272 (41%)
BMI (kg/m2) 23.4 (5.2)
Diabetes 191 (29%)
Insulin therapy 63 (9%)
ASA score:
Grade I 59 (9%)
Grade II 495 (74%)
Grade III 115 (17%)
Cancer 528 (79%)
Pre-operative chemotherapy 34 (5%)
Jaundice 470 (70%)
Haemoglobin serum levels (g/dl) 12.8 (1.5)
Operative time (min) 399 (82)
Operative blood loss (ml) 573 (362)
BMI, body mass index; ASA, American Society of Anesthesiologist.
Data are number of patients (%), or mean (standard deviation).
Table 2 Post-operative outcome of the entire cohort
All patients
(n = 669)
Mortality 29 (4%)
Complications
Patients without complications 243 (37%)
Grade I–II 303 (45%)
Grade III–V 123 (18%)
Pancreatic fistula 201 (30%)
Grade A 103 (15%)
Grade B 61 (9%)
Grade C 37 (6%)
Readmissions 43 (6%)
Length of hospital stay (days) 16.8 (12.7)
Data are number of patients (%), or mean (standard deviation).
Complications graded according to Clavien–Dindo classification.
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At long-term follow-up, insulin-dependent diabetes was more
frequent in patients treated with CP (10/11, 91% versus 5/12, 42%,
P = 0.017). In the group of patients who received AIT (mean
follow-up: 967 days, median follow-up: 930 days, range: 417–
1311); one patient died of post-operative hemorrhagic relapse 6
days after CP and transplantation; one patient was insulin-free
until death occurring 36months after AIT; 3 patients have insulin-
dependent diabetes with a maintained graft function (C-peptide >
Table 3 Patients characteristics at the time of relaparotomy
Pancreas preservation
(n = 17)
Completion
pancreatectomy
P-value
Simple drainage
(n = 10)
Duct occlusion
(n = 7)
(n = 14)
Age (years) 72.1 (11.9) 64.5 (12.0) 59.7 (6.5) 0.236
Gender: male/female 6/4 7/0 12/2 0.517
Pre-operative diabetes 1 (10%) 2 (29%) 1 (7%) 0.385
Cancer 7 (70%) 4 (57%) 10 (71%) 0.690
ASA score: 0.871
Grade III 4 3 6
Grade  IV 6 4 8
Cause of relaparotomy 0.979
Haemorrhage 6 4 9
Sepsis 4 3 5
Day of relaparotomy 13 (4–32) 14 (5–24) 17 (6–42) 0.465
ASA, American Society of Anesthesiologist.
Data are number of patients (%), or mean (standard deviation), or median (range).
P-values are referred to pancreas-preserving procedures versus completion pancreatectomy.
Table 4 Intra- and post-operative outcome of relaparotomy
Pancreas preservation
(n = 17)
Completion
pancreatectomy
P-value
Simple drainage
(n = 10)
Duct
occlusion
(n = 7)
(n = 14)
Operative time (min) 122 (35) 193 (71) 240 (72) 0.001
Operative blood loss (ml)
First relaparotomy 961 (809) 916 (816) 2507 (1976) 0.009
All relaparotomies 3294 (3123) 1583 (829) 2514 (1979) 0.928
Overall transfusions (ml) 2841 (1857) 2719 (1632) 2376 (2399) 0.580
Mortality 3 (30%) 2 (29%) 3 (21%) 0.610
Patients requiring a further relaparotomy 7 (70%) 3 (43%) 1 (7%) 0.003
Total number of reoperations 8 4 1 0.001
Bleeding complications 4 (40%) 3 (43%) 2 (14%) 0.101
Bile leakage 1 (10%) 3 (43%) 3 (21%) 0.889
Delayed gastric emptying 4 (40%) 3 (43%) 5 (36%) 0.756
Medical complications 4 (40%) 3 (43%) 3 (21%) 0.242
Wound infection 2 (20%) 1 (14%) 6 (43%) 0.124
ICU stay
Patients admitted to ICU 5 (50%) 3 (43%) 12 (86%) 0.025
Days of ICU stay 4.7 (6.0) 14.9 (32) 3.5 (2.9) 0.058
Hospital stay (days) after relaparotomy 35.5 (23.7) 32.9 (25.4) 22.4 (13.7) 0.103
ICU, intensive care unit.
Data are number of patients (%) or mean (standard deviation).
P-values are referred to pancreas-preserving procedures compared with a completion pancreatectomy.
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0.3 ng/ml); and 2 patients had loss of function of the graft
(C-peptide < 0.3 ng/ml) and experienced brittle diabetes.
Discussion
A relaparotomy for PF after a pancreaticoduodenectomy is a dra-
matic operation; the patient is often in a critical condition and
high blood loss is expected (about 1000–2500 ml in the present
study) with the risk of damaging the biliary or digestive anasto-
moses. In this scenario, the crucial surgical choice relates to the
preservation of the pancreatic remnant. Compared with a CP,
there are several theoretical advantages in preserving the pancreas:
it is an easier technique, with less blood loss and shorter operative
time. However, the greatest advantage in preserving the stump is
the avoidance of brittle diabetes that invariably follows a CP.6 The
quality of life in patients after a total pancreatectomy has been
reported to be similar to patients with diabetes with different
aetiology.15 However, hypoglycemia-related mortality and compli-
cations, such as nephropathy, neuropathy and retinopathy, should
be taken into consideration, especially in young patients with
benign disease with a long-life expectancy.15–17
Several techniques have been proposed to maintain the pan-
creas during a relaparotomy for PF: drainage of the anastomotic
region, preservation of a small pancreatic remnant, over sewing of
the stump or duct occlusion with fibrin sealant,18 pancreatico-
gastrostomy19 and the bridge stent technique.20 Two of them
(simple drainage and duct occlusion) were applied in the present
study. Compared with SD, duct occlusion is associated with the
resection of the dehiscent jejunal loop, should allow the conver-
sion of an ‘activated’ PF into a ‘pure’ PF, avoiding the mixing of
pancreatic enzymes with bilio-enteric secretions. However, the
potential advantages of DO were not confirmed by our findings,
as the two techniques had similar outcomes. In spite of the theo-
retical advantages of pancreas preservation, this choice was related
to a high risk of persistent PF after relaparotomy. In this setting,
PFmay predispose to further haemorrhagic or septic episodes that
could be fatal in these compromised patients. After pancreas-
preserving techniques, 10 out 17 patients (59%) required a further
relaparotomy after the first one (with two CP at second
relaparotomy), whereas only one out of 14 patients (7%) treated
primarily by CP needed a further operation. The high rate of a
second relaparotomy also caused further blood loss after the first
re-operation, so that, in spite of the significant higher blood loss of
a CP during the first relaparotomy, the overall blood loss and
blood transfusion volume were similar between the different
approaches. A similar observation can be made for ICU stay. The
number of patients admitted to ICU was higher after CP, owing to
the major impact of the procedure, but overall ICU stay was
shorter for patients after CP, and the difference was close to sig-
nificance (0.058). In spite of a reduction in the relaparotomy rate
and ICU stay, mortality was not significantly reduced in the CP
group, although in the last 11 patients treated with this approach
it was 9%.
To encompass the problem of brittle diabetes after CP, islet
auto-transplantation has been seldom reported21,22 but has been
employed successfully since 2008 in our institution. Insulin inde-
pendency was achieved only by one of the six patients surviving
the operation (16.7%). However, in spite of the need for insulin
therapy, graft function was maintained in the other three patients,
so that AIT avoided brittle diabetes in four out of six patients of
this subgroup.
The main limitation of the present study, as well as similar
reports comparing different strategies during relaparotomy for PF,
is the lack of homogeneity of the study group, as patients requir-
ing a relaparotomy may be quite different in terms of clinical
condition and intra-operative findings. We tried to reduce this
selection bias, excluding patients in whom there was no possibility
to choose between pancreas preservation and CP, owing to critical
conditions, anatomic findings or pancreatic necrosis.
In conclusion, CP has become the technique of choice in our
experience when reoperation for PF is needed, as in most cases it
is the definitive operation, avoiding the persistence of activated
pancreatic juice in the operative field. In patients treated with CP,
the association with AIT can reduce the metabolic consequences
of the procedure.
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